How to use this checklist
This checklist suits AI products for clinicians, providers, patients and life sciences.
Work through each list before you contact investors. Anything you cannot tick is either a task to finish or a risk to explain openly in your pitch.
1. Company and legal basics
These apply to every company raising money, but gaps here slow rounds more than almost anything else.
- Up-to-date cap table showing every shareholder, option and convertible.
- Signed IP assignments from all founders, staff and contractors.
- Articles of association and any shareholder agreement to hand.
- SEIS or EIS advance assurance applied for, if you are raising from UK angels.
- Company filings at Companies House up to date.
2. Healthtech proof points
The evidence investors in this sector look for first.
- Intended purpose statement and expected classification.
- Validation on unseen data and a plan for real-world evidence.
- Named clinical champions who use the product.
- A first buyer and the budget line that pays.
3. Numbers and financial model
Your model should show how the money you raise gets you to the next milestone.
- Costed evidence and regulatory plan with timelines.
- Contingency for regulatory delay.
- Grant and partnership funding for studies.
- Milestones each round is meant to reach.
4. Data room documents
Have these organised in one shared folder before the first meeting.
- Quality management documentation.
- Clinical safety case and hazard log where required.
- Data access agreements and lawful basis.
- Security and data protection assessments.
5. Pitch and investor readiness
Readiness is also about how you run the process.
- A short deck that states the problem, customer, traction and ask in the first few slides.
- A clear amount to raise and a list of what it pays for.
- A target list of investors who back your sector and stage.
- A one-paragraph answer to 'why now?'.
Red flags to fix before you pitch
Investors often stop at these issues:
- Marketing claims that change your classification.
- Innovation-budget pilots with no recurring buyer.
- Training data without ongoing rights.
- No contingency if approval slips.
Healthtech readiness: ready versus common gap
| Area | Ready when | Common gap |
|---|---|---|
| Classification | Documented with advice | Assumed not a device |
| Evidence | Costed plan by stage | Retrospective accuracy only |
| Safety | Processes operating | Planned for later |
| Buyer | Budget holder identified | 'The NHS' in general |
Questions to prepare before you pitch
- What does our intended purpose statement say?
- What will our evidence plan cost?
- Who pays, from which budget?
- What happens if approval takes twice as long?
How KJ Enterprises evaluates healthtech businesses
KJ Enterprises considers healthtech businesses with clear regulatory plans, working safety processes and a real first buyer.
If that describes your company, you can apply for investment. Related reading: the complete funding guide and the step-by-step how-to and costs and terms and the machine learning checklist.